Written by LAURAN NEERGAARD

Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 — and if regulators agree, shots could begin within a matter of weeks.

Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German partner BioNTech. Not only can youngsters sometimes get seriously ill, but keeping them in school can be a challenge with the coronavirus still raging in poorly vaccinated communities.

Pfizer announced in a tweet that it had formally filed its application with the Food and Drug Administration.

Now the FDA will have to decide if there’s enough evidence that the shots are safe and will work for younger children like they do for teens and adults. An independent expert panel will publicly debate the evidence on Oct. 26.

One big change: Pfizer says its research shows the younger kids should get a third of the dose now given to everyone else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody levels just as strong as teens and young adults get from regular-strength shots.

While kids are at lower risk of severe illness or death than older people, COVID-19 does sometimes kill children and cases in youngsters have skyrocketed as the extra-contagious delta variant has swept through the country

“It makes me very happy that I am helping other kids get the vaccine,” said Sebastian Prybol, 8, of Raleigh, North Carolina. He is enrolled in Pfizer’s study at Duke University and doesn’t yet know if he received the vaccine or dummy shots.

“We do want to make sure that it is absolutely safe for them,” said Sebastian’s mother, Britni Prybol. But she said she will be “overjoyed” if the FDA clears the vaccine.

Pfizer studied the lower dose in 2,268 volunteers ages 5 to 11, and has said there were no serious side effects. The study isn’t large enough to detect any extremely rare side effects, such as the heart inflammation that sometimes occurs after the second dose of the regular-strength vaccine, mostly in young men.

If the FDA authorizes emergency use of the kid-sized doses, there’s another hurdle before vaccinations in this age group can begin. Advisers to the Centers for Disease Control and Prevention will decide whether to recommend the shots for youngsters, and the CDC will make a final decision.

To avoid dosing mix-ups, Pfizer is planning to ship vials specially marked for pediatric use containing the lower dose.

 

Photo via AP Photo/Robert F. Bukaty.

 

Related Stories
‹
As Measles Cases Mount in the US, What’s the Situation Worldwide?
The U.S. registered its first death from measles since 2015 this week. While more common globally, the virus' numbers are up in recent years.
Sources: US To Recommend COVID Vaccine Boosters at 8 Months
Written by ZEKE MILLER U.S. health experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country. Federal health officials have been actively looking at whether […]
When RFK Jr. Was Presented With the Science on Vaccines He Said He Needed To See, He Dismissed It
Robert F. Kennedy Jr. spent insisted to senators that he’s not anti-vaccine. But he repeatedly refused to acknowledge scientific consensus.
US Clears Updated COVID Boosters Targeting Newest Variants
Written by LAURAN NEERGAARD The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope […]
US Declares Public Health Emergency Over Monkeypox Outbreak
Written by ZEKE MILLER, MIKE STOBBE and MICHAEL BALSAMO The federal government declared a public health emergency Thursday to bolster the response to the monkeypox outbreak that has infected more than 7,100 Americans. The announcement will free up money and other resources to fight the virus, which may cause fever, body aches, chills, fatigue and pimple-like bumps […]
UNC Vice Chancellor for Research Resigns Over Plagiarism, Misconduct
UPDATE: UNC Chancellor Kevin Guskiewicz and Provost Chris Clemons shared a message on Thursday saying they have accepted Terry Magnuson’s resignation as Vice Chancellor for Research. His final day will be Friday. One of UNC’s leaders in research is under federal supervision for engaging in “research misconduct” while filing for grant funding. Terry Magnuson, the […]
Challenges to NC Medicaid Contracts Now Over With Dismissal
Written by THE ASSOCIATED PRESS The end of appeals by two insurance providers fighting how North Carolina’s health department decided who would run its new Medicaid managed-care initiative means legal challenges over the awarding of the contracts are now over. The Court of Appeals last week agreed to accept the voluntary dismissal request by the […]
US Gives Final Clearance to COVID-19 Shots for Kids 5 to 11
U.S. health officials on Tuesday gave the final signoff to Pfizer’s kid-size COVID-19 shot, a milestone that opens a major expansion of the nation’s vaccination campaign to children as young as 5. The Food and Drug Administration already authorized the shots for children ages 5 to 11 — doses just a third of the amount […]
COVID Vaccine: CDC Expands Booster Rollout, OKs Mixing Shots
Written by LAURAN NEERGAARD and MIKE STOBBE Millions more Americans can get a COVID-19 booster and choose a different company’s vaccine for that next shot, federal health officials said Thursday. Certain people who received Pfizer vaccinations months ago already are eligible for a booster and now the Centers for Disease Control and Prevention says specific […]
Pfizer Asks US To Allow COVID Shots for Kids Ages 5 to 11
Written by LAURAN NEERGAARD Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 — and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine […]
›